In vitro and in vivo efficacy of the combination trimethoprim-sulfamethoxazole against clinical isolates of methicillin-resistant Staphylococcus aureus
- PMID: 3488022
- PMCID: PMC180506
- DOI: 10.1128/AAC.29.6.1092
In vitro and in vivo efficacy of the combination trimethoprim-sulfamethoxazole against clinical isolates of methicillin-resistant Staphylococcus aureus
Abstract
The in vitro susceptibilities of 16 independent, geographically distinct clinical isolates of methicillin-resistant Staphylococcus aureus to trimethoprim (TMP) in combination with sulfamethoxazole (SMX) were evaluated. Although methicillin-resistant S. aureus strains appear to be universally resistant to SMX, the combination TMP-SMX was found to be synergistic in vitro (in combination, the MICs of both drugs decreased 6- to 25-fold) as well as in vivo (5- to 6-fold reduction in TMP at 50% effective doses).
Similar articles
-
Treatment of experimental endocarditis due to methicillin-susceptible or methicillin-resistant Staphylococcus aureus with trimethoprim-sulfamethoxazole and antibiotics that inhibit cell wall synthesis.Antimicrob Agents Chemother. 1995 Apr;39(4):953-7. doi: 10.1128/AAC.39.4.953. Antimicrob Agents Chemother. 1995. PMID: 7786002 Free PMC article.
-
In vitro and in vivo activity of coumermycin and other antibacterial agents against methicillin-resistant strains of Staphylococcus aureus.Chemotherapy. 1986;32(6):499-505. doi: 10.1159/000238459. Chemotherapy. 1986. PMID: 3492342
-
[In vitro synergy between sulfamethoxazole and trimethoprim on strains of Staphylococcus aureus sensitive and resistant to methicillin].Pathol Biol (Paris). 1983 May;31(5):429-33. Pathol Biol (Paris). 1983. PMID: 6353335 French.
-
Trimethoprim-sulfamethoxazole as a viable treatment option for infections caused by methicillin-resistant Staphylococcus aureus.Pharmacotherapy. 2005 Feb;25(2):253-64. doi: 10.1592/phco.25.2.253.56956. Pharmacotherapy. 2005. PMID: 15767239 Review.
-
New applications of old antimicrobials.Pediatr Ann. 1986 Jun;15(6):434-5, 438-40. doi: 10.3928/0090-4481-19860601-05. Pediatr Ann. 1986. PMID: 3523401 Review. No abstract available.
Cited by
-
Long-term follow-up trial of oral rifampin-cotrimoxazole combination versus intravenous cloxacillin in treatment of chronic staphylococcal osteomyelitis.Antimicrob Agents Chemother. 2009 Jun;53(6):2672-6. doi: 10.1128/AAC.01504-08. Epub 2009 Mar 23. Antimicrob Agents Chemother. 2009. PMID: 19307354 Free PMC article. Clinical Trial.
-
Bacterial Targets of Antibiotics in Methicillin-Resistant Staphylococcus aureus.Antibiotics (Basel). 2021 Apr 7;10(4):398. doi: 10.3390/antibiotics10040398. Antibiotics (Basel). 2021. PMID: 33917043 Free PMC article. Review.
-
Efficacy of cotrimoxazole (Sulfamethoxazole-Trimethoprim) as a salvage therapy for the treatment of bone and joint infections (BJIs).PLoS One. 2019 Oct 17;14(10):e0224106. doi: 10.1371/journal.pone.0224106. eCollection 2019. PLoS One. 2019. PMID: 31622440 Free PMC article.
-
Methicillin-resistant staphylococci: detection methods and treatment of infections.Antimicrob Agents Chemother. 1989 Jul;33(7):995-9. doi: 10.1128/AAC.33.7.995. Antimicrob Agents Chemother. 1989. PMID: 2675760 Free PMC article. Review. No abstract available.
-
RexAB is essential for the mutagenic repair of Staphylococcus aureus DNA damage caused by co-trimoxazole.Antimicrob Agents Chemother. 2019 Sep 9;63(12):e00944-19. doi: 10.1128/AAC.00944-19. Epub 2019 Oct 7. Antimicrob Agents Chemother. 2019. PMID: 31591116 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical